GoodRx Holdings, Inc. Class A Common Stock (GDRX)
NASDAQ · Healthcare
GoodRx Holdings, Inc. Class A Common Stock Net Income 2020–2025
GoodRx Holdings, Inc. Class A Common Stock annual/quarterly net income history and growth rate from 2020 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- GoodRx Holdings, Inc. Class A Common Stock net income for the quarter ending March 31, 2026 was 1.2 M.
- GoodRx Holdings, Inc. Class A Common Stock net income for the twelve months ending March 31, 2026 was 20.6 M.
- GoodRx Holdings, Inc. Class A Common Stock annual net income for 2025 was 30.4 M, a 85.72% increase from 2024.
- GoodRx Holdings, Inc. Class A Common Stock annual net income for 2024 was 16.4 M, a 284.82% decrease from 2023.
- GoodRx Holdings, Inc. Class A Common Stock annual net income for 2023 was -8.9 M, a 72.99% decrease from 2022.
- GoodRx Holdings, Inc. Class A Common Stock annual net income for 2022 was -32.8 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
GoodRx Holdings, Inc. Class A Common Stock Net Income — FAQ
GoodRx Holdings, Inc. Class A Common Stock (GDRX) net income over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
What is GoodRx Holdings, Inc. Class A Common Stock's net income?
GoodRx Holdings, Inc. Class A Common Stock (GDRX) reported net income of $30M for fiscal 2025.
Where can I see GDRX's net income history?
The chart and table above show GoodRx Holdings, Inc. Class A Common Stock's net income by year and by quarter, including the growth rate.